Somatostatin in Acute Bleeding Oesophageal Varices: Pharmacology and Rationale for Use

Drugs

Volumn 44, Issue 2, 1992, Pages 24-35

  Hanisch, E ^a   Doertenbach, J ^a   Usadel, K H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL HORMONE; GROWTH HORMONE; OCTREOTIDE; SOMATOSTATIN;

AMINO ACID SEQUENCE; ARTERIAL PRESSURE; BLOOD PRESSURE; CELL GROWTH; DOG; ESOPHAGUS VARICES BLEEDING; EXOCRINE SECRETION; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HEART OUTPUT; HEMODYNAMICS; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; INTESTINE BLOOD FLOW; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER CLEARANCE; METABOLIC CLEARANCE RATE; NONHUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL; RAT; REVIEW; RHESUS MONKEY; SPECIES DIFFERENCE; SPLANCHNIC BLOOD FLOW; STOMACH ACID SECRETION; SWINE; SYSTEMIC CIRCULATION; THROMBOCYTE AGGREGATION; URINARY EXCRETION; VASCULAR RESISTANCE; VASOCONSTRICTION;

ACUTE DISEASE; ANIMAL; DOGS; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMICS; HUMAN; MACACA MULATTA; OCTREOTIDE; RATS; SOMATOSTATIN;

EID: 0026484861     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199200442-00005     Document Type: Article

References (82)

1. Somatostatin: regulation of secretion
2. Somatostatin 1-28 circulates in human plasma
3. Octreotide — a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion
4. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
5. A microsphere study on the effects of somatostatin and secretin on regional blood flow in anesthetized dogs
6. La somatostatine diminue l’hypertension portale chez le cirrhotique
7. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin
8. Hypo-thalamic polypeptide that inhibits the section of immunoreactive pituitary growth hormone
9. Randomized, double blind, placebo-controlled trial of somatostatin for variceal bleeding
10. Effect of a long acting analogue of somatostatin (SMS 201-995) on hepatic venous pressures and azygós blood flow in cirrhotics
11. Somatostatin and analogs lack splanchnic vasoconstrictive effects in anesthetized pigs
12. Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension
13. Effect of somatostatin on oesophageal variceal pressure assessed by direct measurement
14. Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle
15. Endocrine profile of a long-acting somatostatin derivative SMS 201-995
16. Hämodynamische Veränderungen nach Somatostatingabe
17. Erstmaliger Nachweis von Somatostatinzellen in der Gallenblase
18. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis
19. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis
20. Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25
21. The effect of graded vasoconstrictor fibre stimulation on the intestinal resistance and capacitance vessels
22. The effect of the sympathetic vasoconstrictor fibres on the distribution of capillary blood flow in the intestine
23. The adrenergic innervation of the vessels supplying and draining the gastrointestinal tract
24. Different effects of three kinds of somatostatin (15-28, 1-14, 1-28) on rabbit’s platelet aggregation
25. In vitro enhancement of human platelet aggregation by somatostatin
26. Somatostatin and diabetes
27. Immunocytochemical evidence for the presence of somatostatin-like immunoreactivity in scattered cells of the duct system of the submandibular glands in the monkey, Macaca irus
28. Further studies on the significance of circulating platelet aggregates induced by somatostatin in man
29. Intestinal blood flow
30. In-vitro-Aktivitätsmuster der Gallenblasenmuskulatur von Steinträgern und NichtSteinträgern-Differenzierte Antwort auf Cholezystokinin, Motilin und Neurotensin
31. Reduction of urinary calcium excretion by a long acting somatostatin analog. Results of a study using human parathyroid tissue transplanted to athymic nude mice
32. Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats
33. Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons
34. Electrophysiology of vascular smooth muscle
35. Reduction in portal vein blood flow by somatostatin
36. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat
37. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man
38. Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat
39. Doisisabhängigkeit der Wirkung von Somatostatin auf die splanchnische Durchblutung beim Menschen
40. Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics
41. Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow and serum gastrin
42. Gastrointestinal secretory, motor, circulatory and metabolic effects of prosomatostatin
43. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats
44. Gastric mucosal protection by somatostatins
45. Portal hypertension, size of esophageal varices, the risk of gastrointestinal bleeding in alcoholic cirrhosis
46. Action of somatostatin on stomach, pancreas, gastric mucosal blood flow and hormones
47. A controlled clinical trial of cimetidine in the recurrence of variceal hemorrhage: implications about the pathogenesis of hemorrhage
48. Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension
49. ’In vivo’ microscopy studies of the hepatic microvascular system
50. The radioimmunoassay and physiology of somatostatin in the pancreas and gastrointestinal tract
51. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension
52. Effects of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosis
53. Haemodynamic effects of subcutaneous administration of SMS 201-995, a long acting somatostatin analog, in patients with cirrhosis and portal hypertension
54. The in vivo metabolism of somatostatin-28: possible relationship between diminished metabolism and enhanced biological action
55. The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis
56. Prevention of pahalloidin-induced lesions on isolated rat hepatocytes by novel synthetic analogues of somatostatin
57. Somatostatin for variceal bleeders (editorial)
58. Somatostatin (first of two parts)
59. Somatostatin (second of two parts)
60. Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels
61. Inhibition by somatostatin of renin, blood pressure, and cardiac and stroke index in essential hypertension
62. Effects of a long-acting somatostatin analogue upon bone. Histomorphometric results of a rat pilot study
63. Low-dose infusion of somatostatin in man — no effect upon intestinal calcium absorption but a fall in blood insulin
64. Comparison of somatostatin and vasopressin in bleeding esophageal varices
65. Circulatory effects of somatostatin in anesthetized dogs
66. Influence of somatostatin on blood pressure and plasma renin activity in the rat
67. Somatostatin — A regulatory modulator connecting nutrient entry and metabolism
68. Basal plasma somatostatin in biliary stone patients
69. Esophageal varices
70. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects
71. Evidence for the release of somatostatin from human thyroid
72. Effect of somatostatin on kidney function and vasoactive hormone systems in healthy subjects
73. Treatment of bleeding esophageal varices with somatostatin
74. Circulatory effects of somatostatin in anesthetized man
75. Occurrence of somatostatin-like immunoreactivity in vagal nerves
76. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices
77. The distribution and characterization of somatostatin-like immunoreactivity in epithelial cells, submucosa, and muscle of the rat stomach and intestine
78. influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus
79. Immunohistochemical demonstration of somatostatin-containing cells in the human, dog and rat thyroids